{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:31:09Z","timestamp":1792791069635,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"ICanCME Research Network","id":[{"id":"https:\/\/ror.org\/04tgjxk96","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["166142"],"award-info":[{"award-number":["166142"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS), and fibromyalgia (FM) are two chronic complex diseases with overlapping symptoms affecting multiple systems and organs over time. Due to the absence of validated biomarkers and similarity in symptoms, both disorders are misdiagnosed, and the comorbidity of the two is often unrecognized. Our study aimed to investigate the expression profiles of 11 circulating miRNAs previously associated with ME\/CFS pathogenesis in FM patients and individuals with a comorbid diagnosis of FM associated with ME\/CFS (ME\/CFS\u2009+\u2009FM), and matched sedentary healthy controls. Whether these 11 circulating miRNAs expression can differentiate between the two disorders was also examined. Our results highlight differential circulating miRNAs expression signatures between ME\/CFS, FM and ME\/CFS\u2009+\u2009FM, which also correlate to symptom severity between ME\/CFS and ME\/CFS\u2009+\u2009FM groups. We provided a prediction model, by using a machine-learning approach based on 11 circulating miRNAs levels, which can be used to discriminate between patients suffering from ME\/CFS, FM and ME\/CFS\u2009+\u2009FM. These 11 miRNAs are proposed as potential biomarkers for discriminating ME\/CFS from FM. The results of this study demonstrate that ME\/CFS and FM are two distinct illnesses, and we highlight the comorbidity between the two conditions. Proper diagnosis of patients suffering from ME\/CFS, FM or ME\/CFS\u2009+\u2009FM is crucial to elucidate the pathophysiology of both diseases, determine preventive measures, and establish more effective treatments.<\/jats:p>","DOI":"10.1038\/s41598-023-28955-9","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T06:06:30Z","timestamp":1675317990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Circulating microRNA expression signatures accurately discriminate myalgic encephalomyelitis from fibromyalgia and comorbid conditions"],"prefix":"10.1038","volume":"13","author":[{"given":"Evguenia","family":"Nepotchatykh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iurie","family":"Caraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam","family":"Elremaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Leveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elbakry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Godbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Rostami-Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Khatami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"28955_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fped.2019.00012","volume":"7","author":"L Chu","year":"2019","unstructured":"Chu, L., Valencia, I. J., Garvert, D. W. & Montoya, J. G. Onset patterns and course of myalgic encephalomyelitis\/chronic fatigue syndrome. Front. Pediatr. 7, 12 (2019).","journal-title":"Front. Pediatr."},{"key":"28955_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1300\/J092v11n01_02","volume":"11","author":"BM Carruthers","year":"2003","unstructured":"Carruthers, B. M. et al. Myalgic encephalomyelitis\/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 11, 7\u2013115 (2003).","journal-title":"J. Chronic Fatigue Syndr."},{"key":"28955_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12967-021-02742-4","volume":"19","author":"R Maksoud","year":"2021","unstructured":"Maksoud, R. et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis\/chronic fatigue syndrome. J. Transl. Med. 19, 81 (2021).","journal-title":"J. Transl. Med."},{"key":"28955_CR4","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.149217","author":"F Hoel","year":"2021","unstructured":"Hoel, F. et al. A map of metabolic phenotypes in patients with myalgic encephalomyelitis\/chronic fatigue syndrome. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.149217 (2021).","journal-title":"JCI Insight"},{"key":"28955_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/CLEP.S39876","volume":"5","author":"S Johnston","year":"2013","unstructured":"Johnston, S., Brenu, E. W., Staines, D. & Marshall-Gradisnik, S. The prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis: A meta-analysis. Clin. Epidemiol. 5, 105\u2013110 (2013).","journal-title":"Clin. Epidemiol."},{"key":"28955_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fped.2018.00412","volume":"6","author":"AR Valdez","year":"2018","unstructured":"Valdez, A. R. et al. Estimating prevalence, demographics, and costs of ME\/CFS using large scale medical claims data and machine learning. Front. Pediatr. 6, 412 (2018).","journal-title":"Front. Pediatr."},{"key":"28955_CR7","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.clinthera.2018.12.016","volume":"41","author":"BH Natelson","year":"2019","unstructured":"Natelson, B. H. Myalgic encephalomyelitis\/chronic fatigue syndrome and fibromyalgia: Definitions, similarities, and differences. Clin. Ther. 41, 612\u2013618 (2019).","journal-title":"Clin. Ther."},{"key":"28955_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/art.38905","volume":"67","author":"GT Jones","year":"2015","unstructured":"Jones, G. T. et al. The prevalence of fibromyalgia in the general population: A comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 67, 568\u2013575 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"28955_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/acr.20156","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe, F. New American College of Rheumatology criteria for fibromyalgia: A twenty-year journey. Arthritis Care Res. (Hoboken) 62, 583\u2013584 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"28955_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe, F. et al. 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 46, 319\u2013329 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"28955_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/qjmed\/hcs156","volume":"106","author":"B Abbi","year":"2013","unstructured":"Abbi, B. & Natelson, B. H. Is chronic fatigue syndrome the same illness as fibromyalgia: Evaluating the \u201csingle syndrome\u201d hypothesis. QJM 106, 3\u20139 (2013).","journal-title":"QJM"},{"key":"28955_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","volume":"9","author":"CE Condrat","year":"2020","unstructured":"Condrat, C. E. et al. miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cells 9, 276 (2020).","journal-title":"Cells"},{"key":"28955_CR13","doi-asserted-by":"publisher","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. 105, 10513\u201310518 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"28955_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semcdb.2017.12.011","volume":"78","author":"K Kai","year":"2018","unstructured":"Kai, K., Dittmar, R. L. & Sen, S. Secretory microRNAs as biomarkers of cancer. Semin. Cell Dev. Biol. 78, 22\u201336 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"28955_CR15","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1089\/neu.2018.6256","volume":"36","author":"S Tigchelaar","year":"2019","unstructured":"Tigchelaar, S. et al. MicroRNA biomarkers in cerebrospinal fluid and serum reflect injury severity in human acute traumatic spinal cord injury. J. Neurotrauma 36, 2358\u20132371 (2019).","journal-title":"J. Neurotrauma"},{"key":"28955_CR16","doi-asserted-by":"publisher","first-page":"650372","DOI":"10.3389\/fnmol.2021.650372","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang, J. & Zhao, J. MicroRNA dysregulation in epilepsy: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development. Front. Mol. Neurosci. 14, 650372 (2021).","journal-title":"Front. Mol. Neurosci."},{"key":"28955_CR17","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/all.14520","volume":"76","author":"K Hirai","year":"2021","unstructured":"Hirai, K. et al. Circulating microRNA-15b-5p as a biomarker for asthma-COPD overlap. Allergy 76, 766\u2013774 (2021).","journal-title":"Allergy"},{"key":"28955_CR18","doi-asserted-by":"publisher","first-page":"105975","DOI":"10.1016\/j.biocel.2021.105975","volume":"135","author":"B Yu","year":"2021","unstructured":"Yu, B. et al. MicroRNA-431-5p encapsulated in serum extracellular vesicles as a biomarker for proliferative diabetic retinopathy. Int. J. Biochem. Cell Biol. 135, 105975 (2021).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"28955_CR19","doi-asserted-by":"publisher","first-page":"19620","DOI":"10.1038\/s41598-020-76438-y","volume":"10","author":"E Nepotchatykh","year":"2020","unstructured":"Nepotchatykh, E. et al. Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology. Sci. Rep. 10, 19620 (2020).","journal-title":"Sci. Rep."},{"key":"28955_CR20","doi-asserted-by":"publisher","first-page":"e78762","DOI":"10.1371\/journal.pone.0078762","volume":"8","author":"JL Bjersing","year":"2013","unstructured":"Bjersing, J. L., Lundborg, C., Bokarewa, M. I. & Mannerkorpi, K. Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One 8, e78762 (2013).","journal-title":"PLoS One"},{"key":"28955_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00296-014-3139-3","volume":"35","author":"JL Bjersing","year":"2015","unstructured":"Bjersing, J. L., Bokarewa, M. I. & Mannerkorpi, K. Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: An exploratory study. Rheumatol. Int. 35, 635\u2013642 (2015).","journal-title":"Rheumatol. Int."},{"key":"28955_CR22","unstructured":"Buron, J.B. Universitat de Barcelona (2020)."},{"key":"28955_CR23","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/ije\/dys160","volume":"42","author":"P Awadalla","year":"2013","unstructured":"Awadalla, P. et al. Cohort profile of the CARTaGENE study: Quebec\u2019s population-based biobank for public health and personalized genomics. Int. J. Epidemiol. 42, 1285\u20131299 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"28955_CR24","unstructured":"Organisation, W.H. International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10)-WHO Version for 2019-covid-expanded. Vol. 2022."},{"key":"28955_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/pharmaceutics11030126","volume":"11","author":"E Almenar-Perez","year":"2019","unstructured":"Almenar-Perez, E., Sanchez-Fito, T., Ovejero, T., Nathanson, L. & Oltra, E. Impact of polypharmacy on candidate biomarker mirnomes for the diagnosis of fibromyalgia and myalgic encephalomyelitis\/chronic fatigue syndrome: Striking back on treatments. Pharmaceutics 11, 126 (2019).","journal-title":"Pharmaceutics"},{"key":"28955_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/2049463719875164","volume":"15","author":"PG McKay","year":"2021","unstructured":"McKay, P. G., Martin, C. R., Walker, H. & Fleming, M. Chronic fatigue syndrome (CFS)\/myalgic encephalomyelitis (ME) and fibromyalgia (FM): The foundation of a relationship. Br. J. Pain 15, 26\u201339 (2021).","journal-title":"Br. J. Pain"},{"key":"28955_CR27","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/ijms22083891","volume":"22","author":"R Siracusa","year":"2021","unstructured":"Siracusa, R., Paola, R. D., Cuzzocrea, S. & Impellizzeri, D. Fibromyalgia: Pathogenesis, mechanisms, diagnosis and treatment options update. Int. J. Mol. Sci. 22, 3891 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"28955_CR28","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1016\/j.mayocp.2021.07.004","volume":"96","author":"L Bateman","year":"2021","unstructured":"Bateman, L. et al. Myalgic encephalomyelitis\/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clin. Proc. 96, 2861\u20132878 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"28955_CR29","doi-asserted-by":"publisher","first-page":"105287","DOI":"10.1016\/j.psyneuen.2021.105287","volume":"131","author":"N Groven","year":"2021","unstructured":"Groven, N., Reitan, S. K., Fors, E. A. & Guzey, I. C. Kynurenine metabolites and ratios differ between chronic fatigue syndrome, fibromyalgia, and healthy controls. Psychoneuroendocrinology 131, 105287 (2021).","journal-title":"Psychoneuroendocrinology"},{"key":"28955_CR30","first-page":"2675","volume":"26","author":"A Korszun","year":"1999","unstructured":"Korszun, A. et al. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J. Rheumatol. 26, 2675\u20132680 (1999).","journal-title":"J. Rheumatol."},{"key":"28955_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2796.2011.02405.x","volume":"271","author":"AR Light","year":"2012","unstructured":"Light, A. R. et al. Gene expression alterations at baseline and following moderate exercise in patients with chronic fatigue syndrome and fibromyalgia syndrome. J. Intern. Med. 271, 64\u201381 (2012).","journal-title":"J. Intern. Med."},{"key":"28955_CR32","doi-asserted-by":"publisher","first-page":"e0174585","DOI":"10.1371\/journal.pone.0174585","volume":"12","author":"J-Q Chen","year":"2017","unstructured":"Chen, J.-Q. et al. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome. PloS One 12, e0174585 (2017).","journal-title":"PloS One"},{"key":"28955_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000381283","volume":"91","author":"S Hamada","year":"2015","unstructured":"Hamada, S., Masamune, A., Kanno, A. & Shimosegawa, T. J. D. Comprehensive analysis of serum microRNAs in autoimmune pancreatitis. Digestion 91, 263\u2013271 (2015).","journal-title":"Digestion"},{"key":"28955_CR34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12035-013-8553-0","volume":"49","author":"G Morris","year":"2014","unstructured":"Morris, G., Berk, M., Galecki, P. & Maes, M. The emerging role of autoimmunity in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/cfs). Mol. Neurobiol. 49, 741\u2013756 (2014).","journal-title":"Mol. Neurobiol."},{"key":"28955_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.imlet.2014.01.009","volume":"161","author":"I Rodriguez-Pint\u00f3","year":"2014","unstructured":"Rodriguez-Pint\u00f3, I., Agmon-Levin, N., Howard, A. & Shoenfeld, Y. Fibromyalgia and cytokines. Immunol. Lett. 161, 200\u2013203 (2014).","journal-title":"Immunol. Lett."},{"key":"28955_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-019-1433-0","volume":"19","author":"M Corbitt","year":"2019","unstructured":"Corbitt, M., Eaton-Fitch, N., Staines, D., Cabanas, H. & Marshall-Gradisnik, S. A systematic review of cytokines in chronic fatigue syndrome\/myalgic encephalomyelitis\/systemic exertion intolerance disease (CFS\/ME\/SEID). BMC Neurol. 19, 1\u201311 (2019).","journal-title":"BMC Neurol."},{"key":"28955_CR37","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.2174\/138161208786549281","volume":"14","author":"JM Krueger","year":"2008","unstructured":"Krueger, J. M. The role of cytokines in sleep regulation. Curr. Pharm. Des. 14, 3408\u20133416 (2008).","journal-title":"Curr. Pharm. Des."},{"key":"28955_CR38","first-page":"358","volume":"29","author":"A G\u00fcr","year":"2002","unstructured":"G\u00fcr, A., Karako\u00e7, M., Nas, K., Denli, A. & Sara\u00e7, J. Cytokines and depression in cases with fibromyalgia. J. Rheumatol. 29, 358\u2013361 (2002).","journal-title":"J. Rheumatol."},{"key":"28955_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga, R. et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2013A target for novel cancer therapy. Cancer Treat. Rev. 63, 40\u201347 (2018).","journal-title":"Cancer Treat. Rev."},{"key":"28955_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/929720","volume":"2015","author":"D Peterson","year":"2015","unstructured":"Peterson, D. et al. Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome\/myalgic encephalomyelitis. Mediat. Inflamm. 2015, 1\u20134 (2015).","journal-title":"Mediat. Inflamm."},{"key":"28955_CR41","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3181\/0712-RM-328","volume":"233","author":"Z Zhang","year":"2008","unstructured":"Zhang, Z. et al. High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia. Exp. Biol. Med. 233, 1171\u20131180 (2008).","journal-title":"Exp. Biol. Med."},{"key":"28955_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-12-804214-4.00011-7","volume-title":"Cytokine Effector Functions in Tissues","author":"P Lacy","year":"2017","unstructured":"Lacy, P. Eosinophil cytokines in allergy. In Cytokine Effector Functions in Tissues (ed. Lacy, P.) 173\u2013218 (Elsevier, 2017)."},{"key":"28955_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/ard.2002.004762","volume":"63","author":"H Sprott","year":"2004","unstructured":"Sprott, H. et al. Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann. Rheum. Dis. 63, 245\u2013251 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"28955_CR44","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.18632\/oncotarget.6708","volume":"7","author":"Y-Y Liao","year":"2016","unstructured":"Liao, Y.-Y. et al. CCL3 promotes angiogenesis by dysregulation of miR-374b\/VEGF-A axis in human osteosarcoma cells. Oncotarget 7, 4310\u20134325 (2016).","journal-title":"Oncotarget"},{"key":"28955_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cyto.2015.11.018","volume":"78","author":"A Landi","year":"2016","unstructured":"Landi, A., Broadhurst, D., Vernon, S. D., Tyrrell, D. L. J. & Houghton, M. Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis\/chronic fatigue syndrome. Cytokine 78, 27\u201336 (2016).","journal-title":"Cytokine"},{"key":"28955_CR46","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1152\/japplphysiol.01031.2003","volume":"96","author":"RM Kraus","year":"2004","unstructured":"Kraus, R. M., Stallings, H. W. III., Yeager, R. C. & Gavin, T. P. Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. J. Appl. Physiol. 96, 1445\u20131450 (2004).","journal-title":"J. Appl. Physiol."},{"key":"28955_CR47","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","volume":"25","author":"JE Ware Jr","year":"2000","unstructured":"Ware, J. E. Jr. SF-36 health survey update. Spine 25, 3130\u20133139 (2000).","journal-title":"Spine"},{"key":"28955_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"E Smets","year":"1995","unstructured":"Smets, E., Garssen, B., Bonke, B. D. & De Haes, J. C. J. M. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 39, 315\u2013325 (1995).","journal-title":"J. Psychosom. Res."},{"key":"28955_CR49","doi-asserted-by":"publisher","DOI":"10.16966\/2379-7150.114","author":"LA Jason","year":"2015","unstructured":"Jason, L. A. et al. Factor analysis of the DePaul Symptom Questionnaire: Identifying core domains. J. Neurol. Neurobiol. https:\/\/doi.org\/10.16966\/2379-7150.114 (2015).","journal-title":"J. Neurol. Neurobiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28955-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28955-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T07:12:46Z","timestamp":1675581166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28955-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28955"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28955-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"29 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M. is Director of Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis (ICanCME) Research Network, a national research network funded by The Canadian Institutes of Health Research (grant MNC\u2014166142 to A.M.) and a Member of the Scientific Advisory Board of the Open Medicine Foundation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1896"}}